Tag Archives: AMONG

New FDA-approved cystic fibrosis medicine, Trikafta®, among other specialty drugs available through AllianceRx Walgreens Prime – BioSpace

  ORLANDO, Fla., Jan. 6, 2020 /PRNewswire/ — AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the U.S., is pleased to include Trikafta® (elexacaftor/tezacaftor/ivacaftor and ivacaftor), a new breakthrough therapy for cystic fibrosis (CF), among other specialty medications available through its pharmacy. Cystic fibrosis is a rare, progressive, life-threatening disease… Read More »

Outbreak of virulent recombinant HIV strain reported among gay men in Paris region

Public health officials in France have reported an outbreak of a recombinant strain of HIV characterised by a high viral load during early infection and rapid loss of CD4 cells.  The outbreak involved X4 tropic virus, usually associated with more advanced HIV, and is reported in Eurosurveillance by a team led by Dr Marc Wirden… Read More »

Potential drug interactions among people with HIV taking statins

Drug interactions remain a potential problem for HIV-positive people who are treated with statins, according to research published in the December issue of the Journal of the American Heart Association. Potential interactions were detected between statins and modern antiretroviral drugs – especially cobicistat – and also medications used to treat other illnesses that are now common… Read More »